There was a lot of importance aimed at the MYIOU 2.0 release earlier last year when the forum was bombarded with posts about app reviews. Bit quiet on that front now that it is happening this month?
Tie that in with the work being done increasing the size and robustness of their back end facilities and to top it off the staff increases. It can't be a coincidence, software doesn't get overhauled for a company that is plodding along. It would have been patched and moved forward, they are clearly anticipating growth this year at a rate that is beyond building simultaneously as it grows. The volume will turn and it will climb again, at this price you can't argue the reward to risk. People are trapped into comparing it to the highs of last year and feel it is underachieving but it's not. It got manipulated, then traded hard (just like every single ASX listed BNPL at the time,) and at its peak IOU was crafty enough to CR and start to build what is coming into fruition now.
Feel like a broken record........
- Forums
- ASX - By Stock
- OVT
- $1 Club
$1 Club, page-29395
-
-
- There are more pages in this discussion • 2,932 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OVT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.005(13.9%) |
Mkt cap ! $83.23M |
Open | High | Low | Value | Volume |
3.5¢ | 4.4¢ | 3.4¢ | $4.062M | 104.3M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1562346 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 390000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1562346 | 0.041 |
8 | 1629950 | 0.040 |
6 | 591369 | 0.039 |
9 | 1690786 | 0.038 |
10 | 960711 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 300000 | 1 |
0.043 | 1762203 | 9 |
0.044 | 2055361 | 13 |
0.045 | 5581165 | 19 |
0.046 | 2957443 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
OVT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online